| Symbol | Company | Weighting |
|---|---|---|
| SRRK | SCHOLAR ROCK HLDG CORP USD | 5.01% |
| AKRO | AKERO THERAPEUTICS INC | 4.34% |
| RYTM | RHYTHM PHARMACEUTICALS INC | 3.25% |
| ARGX | ARGENX SE ADR | 3.15% |
| NTRA | NATERA INC | 2.72% |
| ASND | ASCENDIS PHARMA A/S DKK 1.0 ADR | 2.70% |
| BSX | BOSTON SCIENTIFIC | 2.59% |
| TARS | TARSUS PHARMACEUTICALS | 2.58% |
| MCK | MCKESSON CORP | 2.53% |
| ISRG | INTUITIVE SURGICAL INC | 2.52% |
| LNTH | LANTHEUS HOLDINGS INC | 2.48% |
| ALKS | ALKERMES INC | 2.26% |
| SYK | STRYKER CORP | 2.14% |
| SNY | SANOFI- AVENTIS- ADR | 2.14% |
| VRTX | VERTEX PHARMACEUTICALS INC | 2.13% |
| RNA | AVIDITY BIOSCIENCES INC | 2.09% |
| NUVL | NUVALENT INC | 2.04% |
| HCA | HCA HOLDINGS INC | 1.97% |
| INSP | INSPIRE MEDICAL SYSTEMS, INC. | 1.92% |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 1.81% |
| LLY | ELI LILLY CORP | 1.80% |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 1.77% |
| AZN | ASTRAZENECA PLC-ADR | 1.75% |
| EXAS | EXACT SCIENCES CORP | 1.71% |
| ZTS | ZOETIS INC | 1.67% |
| AMGN | AMGEN CORP | 1.66% |
| BDX | BECTON DICKINSON & CO | 1.63% |
| EW | EDWARDS LIFESCIENCES CORP | 1.63% |
| IONS | IONIS PHARMACEUTICALS INC | 1.57% |
| BMRN | BIOMARIN PHARAMCEUTICAL INC | 1.56% |
| IDXX | IDEXX LABS CORP | 1.54% |
| DNLI | DENALI THERAPEUTICS INC. | 1.54% |
| ELV | ELEVANCE HEALTH INC | 1.49% |
| NBIX | NEUROCRINE BIOSCIENCES INC | 1.47% |
| UNH | UNITEDHEALTH GROUP INC | 1.46% |
| DHR | DANAHER CORP | 1.43% |
| CYTK | CYTOKINETICS INC | 1.36% |
| SNDX | SYNDAX PHARMACEUTICALS, INC. | 1.33% |
| MRK | MERCK & CO. NEW | 1.21% |
| REGN | REGENERON PHARMACEUTICALS | 1.18% |
| TMO | THERMO FISHER SCIENTIFIC INC | 1.17% |
| ARWR | ARROWHEAD PHARMACEUTICALS INC | 1.06% |
| WST | WEST PHARMACEUTICAL SERVICES INC | 1.04% |
| DXCM | DEXCOM INC | 1.02% |
| CRL | CHARLES RIVER LABORATORIES INT INC | 1.01% |
| IMVT | IMMUNOVANT INC | 1.00% |
| AVTR | AVANTOR, INC. | 0.98% |
| BIIB | BIOGEN INC | 0.96% |
| NVO | NOVO NORDISK A/S | 0.95% |
| XNCR | XENCOR INC. | 0.91% |
| PCVX | VAXCYTE INC | 0.90% |
| SRPT | SAREPTA THERAPEUTICS INC | 0.89% |
| APLS | APELLIS PHARMACEUTICALS INC | 0.89% |
| VKTX | VIKING THERAPEUTICS, INC. | 0.81% |
| DYN | DYNE THERAPEUTICS, INC. | 0.81% |
| TNDM | TANDEM DIABETES CARE INC | 0.68% |
| ACHC | ACADIA HEALTHCARE CO INC | 0.67% |
| KURA | KURA ONCOLOGY INC | 0.56% |
| ARVN | ARVINAS INC USD | 0.56% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Private Investments, LLC. Securities offered through Guggenheim Funds Distributors, LLC.
© 2025 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.